ePharma Physician® Provides Pharma Marketers In-Depth Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPads

NEW YORK, Aug. 12 /PRNewswire/ -- Pharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician®, its study focused on physicians connecting with pharmaceutical and biotech companies through the Internet, tech-enabled reps, and online promotion. ePharma Physicians comprise 88% of the U.S. physician population in 2010, up from 64% in 2006.

Manhattan Research broadened the topical focus of ePharma Physician® this year to analyze the growing number of touch points in the pharma-physician relationship. Electronic sampling, live video detailing, and physician use of mobile devices, including iPads, are a few of the topics with new and exciting data. Pharmaceutical and biotech companies, agencies, and medical content providers use the data to inform decision making when leveraging digital channels to interact with physicians. The study can be segmented to derive statistically relevant insights across more than 25 specialties.

Key topics:

Channel Mix: Online and offline sources used for pharma product information; display and search engine advertising; medical journals; specialty and professional medical websites; influence on prescribing behavior

Mobile: Interest in pharma activities on mobile devices; iPad ownership and purchase intent; professional activities conducted on the iPad

Rep Relationship and Tech Detailing: Rep use/attitudes, including reps using Tablet PC or iPad; desired rep services

Online Promotion: Types of e-detailing and non-personal promotion (NPP) used, number of times used, program duration; live video detailing; KOL-led speaker programs; HCP portals/microsites; online promotion attitudes, influence, and barriers; preferences for obtaining product information; ranking of e-detailing and video detailing programs by company (use and satisfaction)

Online Pharmaceutical Properties: Pharma product, corporate, service portal, and unbranded websites

Customer Service: Customer service portal use and features of interest; live online speaker events from pharma companies; preferences for communicating with reps and MSLs; interest in customer service through email, click-to-chat, click-to-call, video chat, and phone; reasons for registering for a service portal

Electronic Sampling: Use and frequency; preferences for obtaining samples

Complimentary White Paper

To access a complimentary white paper from ePharma Physician® v10.0, please visit http://www.manhattanresearch.com/research/white-papers/online-communication-physicians-pharma.aspx.

About ePharma Physician®

ePharma Physician® v10.0 was conducted via online survey in Q2 2010 among 1,713 U.S. physicians who have looked online for pharmaceutical information, visited a pharmaceutical or biotech product or corporate website, or participated in an e-detailing program from a pharmaceutical or biotech company in the past 12 months.

For additional information, please visit http://www.manhattanresearch.com/epp, contact [email protected], or call 1.888.680.0800, ext. 2.

About Manhattan Research

Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers. Broad consumer and physician research is complemented by analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please contact [email protected] or visit http://www.manhattanresearch.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Manhattan Research